Abstract: The invention relates to anionically modified copolymers that can be produced by the polymerization of monomers (A), (B) and (C) to obtain non-ionic polymers with reactive terminal OH groups and by the subsequent reaction of the terminal OH groups to form anionic end groups. According to the invention, (A) is a monomer of formula (I), in which A represents C2-C4 alkene and B represents a C2-C4 alkene that is different from A, R represents hydrogen or methyl, m is a number between 1 and 500, n is a number between 1 and 500, (B) is an ethylenically unsaturated monomer containing an aromatic group and (C) is a ethylenically unsaturated monomer.

Abstract: The invention relates to a copolymer that can be obtained by the polymerisation of monomers (A), (B) and (C), (A) being a monomer of formula (I), in which A represents a C2 to C4alkene and B represents a C2 to C4alkene that is different from A, R represents hydrogen or methyl, m is a number between 1 and 500, n is a number between 1 and 500, (B) is an ethylenically unsaturated monomer containing an aromatic group and (C) is an ethylenically unsaturated monomer containing an alkyl radical. The claimed copolymers are suitable for use as dispersants for pigments.

Abstract: A novel class of polymers obtainable by copolymerising a monomer mixture comprising (i) hydrophilic monomer of general formula (I) Y—B—X; (ii) styrene or a substituted styrene, a monomer or mixture of monomers which when polymerized form a polymer with a Tg lower than the Tg of a homopolymer of monomer (I) and lower than the Tg of a homopolymer of monomer (ii); and a monomer having a crosslinkable group is described. The invention also relates to a method for producing such polymers, implants coated with the polymers and methods for forming the same.

Abstract: The present invention relates to an inhibitor capable of increasing accuracy of the reaction in hybridization, and inhibiting nonspecific hybridization, a clinical diagnostic reagent, and a method of clinical analysis whereby nonspecific hybridization in clinical analysis is inhibited, and a target nucleic substance is detected easily with high accuracy. The inhibitor and the clinical diagnostic reagent contains polymer (H) having a nonspecific hybridization inhibitory action. The polymer has in its molecule at least one of carboxyl and sulfone groups, and phosphorylcholine-like groups, and has a weight average molecular weight of 1000 to 5000000. The method of clinical analysis includes contacting a sample with a test agent capable of hybridizing with a specific nucleic substance in the presence of the inhibitor.

Abstract: There is provided a copolymer and polymeric particle comprising the copolymer, a method of producing a polymeric particle, a copolymeric binder, a method of producing a copolymeric binder, a near infrared radiation-sensitive coating composition, a negative working lithographic offset printing plate, a method of producing a negative working lithographic offset printing plate and methods of imaging the plate and printing with the imaged plate.

Abstract: The present invention is a method for making a polymeric bead by suspension polymerization processes from a phosphoric acid monoester.

Abstract: The present invention relates to a method of producing a polymerizable phosphate containing at least one selected from polymerizable phosphates represented by formula (II), (III) or (IV) by a batch reaction, including a step of adding a compound represented by formula (I) into a mixture of a polymerizable phosphate reaction product containing at least one selected from polymerizable phosphates represented by formula (II), (III) or (IV), obtained by a pre-batch reaction, and phosphoric acid anhydride to react them: wherein R1 represents H or a C1-4 alkyl group, R2 represents a C2-6 alkylene group and n denotes an integer from 1 to 3.

Abstract: Copolymers are manufactured to include a zwitterionic monomer (e.g., methacryloyloxyethyl phosphorylcholine monomer), a dihydroxyphenyl derivatized monomer, and optionally one or more additional monomers. The dihydroxyphenyl derivatized monomer gives the copolymers excellent adhesion properties. Optional monomers include a cationic amino monomer, a hydrocarbon monomer, and/or a hydrophilic monomer. The copolymers are biocompatible and can be used with medical devices.

Abstract: Disclosed herein are functionalized polymers comprising ethylene and substituted ethylene segments. These functionalized polymers are useful as film forming resins in cathodic electrocoating compositions. Also disclosed herein are aqueous dispersion compositions comprising the functionalized polymers and a process for coating various electrically conductive substrates.

Abstract: An intermediate transfer media, such as a belt, that includes a polyaniline grafted to or chemically bonded to a perfluoropolyether phosphoric acid polymer.

Abstract: One-part self-etching, self-priming dental adhesive composition having a pH of at most 2, which comprises (a) a polymerizable acidic phosphoric acid ester monomer (b) one or more polymerizable acidic monomers (c) a polymerizable N-substituted alkylacrylic or acrylic acid amide monomer; (d) optionally an organic and/or inorganic acid; (e) an organic water soluble solvent and/or water; and (f) polymerization initiator, inhibitor and stabilizer.

Abstract: Amphiphilic biomimetic phosphorylcholine-containing silicone compounds for use in both topical and internal applications as components in biomedical devices. The silicone compounds, which include zwitterionic phosphorylcholine groups, may be polymerizable or non-polymerizable. Specific examples of applications include use as active functional components in ophthalmic lenses, ophthalmic lens care solutions, liquid bandages, wound dressings, and lubricious and anti-thrombogenic coatings.

Abstract: The invention provides surfactant-containing cosmetic, dermatological, and pharmaceutical agents comprising at least one water-soluble or water-swellable copolymer obtainable by free-radical copolymerization of A) acryloyldimethyltaurine and/or acryloyldimethyltaurates, B) if desired, one or more further olefinically unsaturated, noncationic comonomers, C) if desired, one or more olefinically unsaturated, cationic comonomers, D) if desired, a silicon-containing component(s), E) if desired, a fluorine-containing component(s), F) if desired, one or more macromonomers, G) the copolymerization taking place if desired in the presence of at least one polymeric additive, H) with the proviso that component A) is copolymerized with at least one component selected from one of the groups D) to G).

Abstract: The invention is directed to the use of maleic esters selected from compounds of formulae (I), (II) and (III), as copolymerizable emulsifiers in the emulsion polymerization of olefinically unsaturated monomers, in which A is a C3-C40 alkyl group; X, Y and Z independently are hydrogen or methyl; B and D independently are sulfate, phosphate or hydrogen; n and p independently are numbers in the range from 0 to 40; and m is a number in the range from 2 to 40.

Abstract: A one-part, self-etching dental adhesive is disclosed. The adhesive includes a hydrolytically stable acidic adhesive monomer and a hydrolytically stable, difunctional hydrophilic monomer.

Abstract: This invention relates to waterborne coatings with enhanced early water blushing resistance, chemical resistance, and adhesion to substrates. These waterborne coatings can be paints, varnishes, and water sealers that offer excellent early water blushing as well as excellent resistance to common household chemicals, such as gasoline, motor oil, brake fluid, transmission fluid, household cleaners, window cleaning fluids, antifreeze, and the like.

Abstract: This invention provides a multistage emulsion polymer including, as copolymerized units: from 0.5% to 5%, by weight P-acid monomer, based on the weight of the emulsion polymer; from 0% to 0.05% by weight multiethylenically unsaturated monomer, based on the weight of the emulsion polymer; and at least one second monoethylenically unsaturated monomer; the emulsion polymer having a calculated Tg of from ?20° C. to 50° C.; the emulsion polymer is formed by the “pulsed” addition of 75% to 100% of the P-acid monomer during a stage including from 10% to 50% of the total monomer weight, preferably added during the relatively early stages of the polymerization. A multistage polymer/TiO2 composite particle and an aqueous coating composition including the composite particle are also provided.

Abstract: A polymerizable composition contains: (A) a polymer compound having (a1) a repeating unit having a structure represented by the following formula (a1-1) in a side chain thereof; and (B) a polymerization initiator, and in the formula (a1-1), R11 and R12 each independently represents a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group, a sulfo group, an alkylsulfonyl group, a arylsulfonyl group, an acyl group, an aryloxycarbonyl group, an alkoxycarbonyl group or a carbamoyl group, R13, R14 and R15 each independently represents a hydrogen atom, an alkyl group or an aryl group, L1 represents a divalent connecting group, Y1 represents a single bond or a divalent connecting group selected from the group consisting of —CO—, —O—, —HN—, a divalent aliphatic group, a divalent aromatic group and a combination of these groups, and * indicates a site connecting to a main chain of the polymer compound.

Abstract: An object of the present invention is to provide a binder resin for a conductive paste, which can be used to obtain a conductive paste having a high conductive powder dispersibility, an ability to form high-aspect-ratio lines, and a low residual carbon content after firing. Further objects of the invention are to provide a conductive paste and a solar cell element produced using such a binder resin for a conductive paste. The invention provides a binder resin for a conductive paste, which includes a polymer having a main chain composed of a segment derived from a (meth)acrylate monomer and having also a phosphoric acid-based component represented by general formula (1) below at an ? position thereon. In general formula (1), X is an oxygen atom or a sulfur atom, and R1 and R2 are each a hydrogen atom, a hydrocarbon group having 1 to 13 carbon atoms, a hydroxyl group-containing group having 1 to 13 carbon atoms or an ester bond-containing group having 1 to 13 carbon atoms.

Abstract: The invention relates to a copolymer having: A) at least one monomer unit a) derived from at least one ethylenically unsaturated aliphatic monocarboxylic or polycarboxylic acid, a corresponding anhydride, or a corresponding water-soluble salt; B) at least one monomer unit b) derived from a particular sulfonated or sulfated ethylenically unsaturated ether or at least one monomer unit (b?) derived from a sulfonated ethylenically unsaturated monomer other than (b), C) at least one monomer unit (c) derived from a monomer with the average general formula [CH2?CH—CH2—R6—O—]xP(?O)(OM)3-x. The invention also relates to a method for preparing such a copolymer, an inhibitor composition including such a copolymer, and a method for inhibiting inorganic deposits in a petroleum reservoir by means of said inhibitor composition.

Abstract: Described herein are new phosphonic polymers and methods of making and using the same. The polymers are prepared by the polymerization of phosphonic acid monomers with hypophosphorous acid, an alkali metal hypophosphite, an alkyl substituted hypophosphite, or any combination thereof. The resultant polymers have pendant phosphonate groups attached to the polymer backbone as well as phosphinate groups incorporated within the polymer backbone. Additional monomers can be used to produce copolymers, terpolymers, and the like. The polymers described herein have numerous applications with respect to inhibiting scale formation and corrosion in a number of systems.

Abstract: Copolymers are manufactured to include a zwitterionic monomer (e.g., methacryloyloxyethyl phosphorylcholine monomer), a dihydroxyphenyl derivatized monomer, and optionally one or more additional monomers. The dihydroxyphenyl derivatized monomer gives the copolymers excellent adhesion properties. Optional monomers include a cationic amino monomer, a hydrocarbon monomer, and/or a hydrophilic monomer. The copolymers are biocompatible and can be used with medical devices.

Abstract: The invention generally relates to zwitterionic polymers (including zwitterionic copolymers), such as polymethacrylic structures, with pendent functional moieties, such as therapeutic or biologic moieties. More particularly, the invention relates to phosphorylcholine-substituted methacrylic polymers prepared by free radical polymerization and click chemistry, for example, and compositions and products comprising same, as well as related methods and uses of the compositions, for example, as biological or therapeutic agents and in drug delivery thereof.

Abstract: The invention provides a silicone monomer which is suitable for the manufacture of ophthalmic devices, such as contact lenses, intraocular lenses, and keratoprosthesis, a monomer composition containing the monomer, and a polymer which fulfills both surface hydrophilicity and oxygen permeability at the same time. The silicone monomer of the present invention is represented by the formula (1a) or (1b): (X: a monovalent C2 to C6 organic group having one or more —OH and optionally one 0 or N in its main chain; Z1 to Z9: a C1 to C4 alkyl group; n: 1 to 3; a and b: 0 or 1).

Abstract: The invention relates to phosphorus-containing mixtures containing compounds of the formula RO—PO(A)-CH2—CH2—CO2H and??(I) HO—PO(A)-CH2—CH2—CO2R??(II) in which A is C1-C18-alkyl, C6-C18-alkylaryl, C6-C18-aralkyl or aryl, R is (D,E)C?C(B, R5) or H B, D, E are identical or different and are each H or C1-C18-alkyl R5 is —CO-alkoxy, a process for their preparation and their use.

Abstract: The invention provides surfactant-free cosmetic, pharmaceutical, and dermatological compositions comprising at least one copolymer obtainable by free-radical copolymerization of A) acryloyldimethyltaurine and/or acryloyldimethyltaurates, B) if desired, one or more further olefinically unsaturated, noncationic comonomers, C) if desired, one or more olefinically unsaturated, cationic comonomers, D) if desired, one or more silicon-containing components, E) if desired, one or more fluorine-containing components, F) if desired, one or more macromonomers, G) the copolymerization taking place if desired in the presence of at least one polymeric additive, H) with the proviso that component A) is copolymerized with at least one component selected from one of the groups.

Abstract: To provide surface-treating agents that can provide excellent hydrophobicity to powder and can improve its rinsability, to provide surface-treated powders that are treated with the surface-treating agent, and to provide cosmetics that comprise the surface-treated powder. A surface-treating agent consisting of a polymer which comprises a monomer (A) represented by the general formula (1) described below as a constituent monomer. (wherein R1 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R2 represents an alkylene group having 4 to 22 carbon atoms, X1 represents an —NH— group or an oxygen atom, and M1 represents a hydrogen atom or a monovalent inorganic or organic cation.

Abstract: Phosphate-containing polycarboxylate polymer dispersant compositions of the invention comprise a polymer made from polyoxyalkylene groups, acrylic acid groups, mono-ester groups, and optionally di-ester and tri-ester groups, all in specific molar ratios. The polymer dispersants of the invention achieve quick mix-in dispersibility, particularly within hydratable cementitious compositions such as concrete, in comparison with polycarboxylate polymer dispersants that do not contain phosphate groups, while having improved initial slump as well as slump retention compared to phosphate-containing polymers of the prior art.

Abstract: A paper or paper board coated with an aqueous paper coating composition containing pigment having a phosphorous-containing emulsion polymer and a phosphorous-containing dispersant.

Abstract: Disclosed is a method for producing a norbornene monomer composition, a norbornene polymer produced using the norbornene monomer composition, an optical film including the norbornene polymer, and a method for producing the norbornene polymer. The method includes reacting a reaction solution that contains cyclopentadiene, dicyclopentadiene, or a mixture of cyclopentadiene and dicyclopentadiene, an acetate compound, and a solvent so that a content of an exo isomer is 50 mol % or more. Variables such as a reaction temperature, a reaction time, a molar ratio between reactants, and addition of a solvent are controlled so that the exo isomer is contained in content of 50 mol % or more. Accordingly, it is possible to industrially produce an acetate norbornene addition polymer by using the acetate norbornene monomer composition containing the exo isomer in content of 50 mol % or more.

Abstract: This invention relates to compounds of formulae (1a) and (1b) wherein R means H or C1- to C6-alkyl, X is a structural unit selected from the formulae wherein m and k mean independently from each other a number from 1 to 12 for (4) and (5) and from 1 to 11 for (6), Y is a structural unit selected from the formulae wherein a, b independently from each other are integers from 1 to 10 R means hydrogen or C1- to C6-alkyl R2 means an alkylene or alkylidene group having 1 to 6 carbon atoms or an arylene or alkylarylene group having from 6 to 20 carbon atoms R3, R4, R5, R6 independently from each other mean an alkylene or alkylidene group having 1 to 6 carbon atoms or an arylene or alkylarylene group having from 6 to 20 carbon atoms, Z means a cation, and n means an integer being two or higher.

Abstract: Copolymers are manufactured to include a zwitterionic monomer (e.g., methacryloyloxyethyl phosphorylcholine monomer), a dihydroxyphenyl derivatized monomer, and optionally one or more additional monomers. The dihydroxyphenyl derivatized monomer gives the copolymers excellent adhesion properties. Optional monomers include a cationic amino monomer, a hydrocarbon monomer, and/or a hydrophilic monomer. The copolymers are biocompatible and can be used with medical devices.

Abstract: The present invention is directed to a network composition having the reaction product of: (i) at least one anionic polymerizable ethylenically unsaturated monomer (I) selected from the group consisting of [CH2?C(R3)C(O)OXa(C2H4O)b(C3H6O)c(C4H8O)d]pP(O)(OY)q(OZ)r where R3?H or alkyl of 1 to about 6 carbon atoms; X=alkyl, aryl, or alkaryl diradical connecting group of 0 to about 9 carbon atoms; a is 0 to about 100; b is 0 to about 100; c is 0 to about 100; d is 0 to about 100; q is 0 to about 2; r is 0 to about 2; p is 1 to about 3 subject to the limitation that p+q+r=3; and Y and Z is H, or metal ion; and CH2?C(R3)C(O)OXa?(C2H4O)b?(C3H6O)c?(C4H8O)d?—SO3—Y) where R3?H or alkyl of from 1 to about 6 carbon atoms; X=alkyl, aryl, or alkaryl diradical connecting group of 0 to about 9 carbon atoms; a? is 0 to about 100; b? is 0 to about 100; c? is 0 to about 100; d? is 0 to about 100; Y is H, or metal ion; and (ii) one or more additional monomers (II) selected from the group consisting of acrylic a

Abstract: The present invention provides for a household, agricultural, coating or personal care product composition containing the crosslinked reaction product of a network composition the reaction product of: (i) at least one anionic polymerizable ethylenically unsaturated monomer (I) selected from the group consisting of [CH2?C(R3)C(O)OXa(C2H4O)b(C3H6O)c(C4H8O)d]pP(O)(OY)q(OZ)r where R3?H or alkyl of 1 to about 6 carbon atoms; X=alkyl, aryl, or alkaryl diradical connecting group of 0 to about 9 carbon atoms; a is 0 to about 100; b is 0 to about 100; c is 0 to about 100; d is 0 to about 100; q is 0 to about 2; r is 0 to about 2; p is 1 to about 3 subject to the limitation that p+q+r=3; and Y and Z is H, or metal ion; and CH2?C(R3)C(O)OXa?(C2H4O)b?(C3H6O)c?(C4H8O)d?—SO3—Y) where R3?H or alkyl of from 1 to about 6 carbon atoms; X=alkyl, aryl, or alkaryl diradical connecting group of 0 to about 9 carbon atoms; a? is 0 to about 100; b? is 0 to about 100; c? is 0 to about 100; d? is 0 to about 100; Y is H

Abstract: Method for producing phosphoric acid ester-based polymer by copolymerizing monomer 1 of formula (1), monomer 2 of formula (2), and monomer 3 of formula (3): wherein the variables are as defined in the specification; wherein the variables are as defined in the specification; and wherein the variables are as defined in the specification, at pH ?7 in solvent having dissolved oxygen concentration of 0.01-4.0 mg/kg, or in presence of phosphonic acid-based chelating agent, or by mixing monomers 1 to 3 at 10-50 ° C., initiating polymerization within 72 hours, and maintaining the temperature at 10-50 ° C. until polymerization is initiated. The phosphoric acid ester-based polymer may be used as a dispersant in a hydraulic composition.

Abstract: The compound represented by general formula (I) below: wherein R10 represents hydrogen atom or methyl group; X represents —O(C?O)— or the like; and R represents hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, or the like, and a polymer obtained by polymerizing a polymeric compound comprising the compound, which are useful for manufacturing hydrophilic polymer materials of high biocompatibility.

Abstract: Copolymers are manufactured to include a zwitterionic monomer (e.g., methacryloyloxyethyl phosphorylcholine monomer), a dihydroxyphenyl derivatized monomer, and optionally one or more additional monomers. The dihydroxyphenyl derivatized monomer gives the copolymers excellent adhesion properties. Optional monomers include a cationic amino monomer, a hydrocarbon monomer, and/or a hydrophilic monomer. The copolymers are biocompatible and can be used with medical devices.

Abstract: An assembly for use in orthodontic treatment includes at least two articles, and each article includes an orthodontic appliance as well as an adhesive that extends across the base of each appliance. The adhesive of at least one article differs from the adhesive of at least one other article in terms of composition, properties or characteristics, such that the adhesive can be tailored to enhance the bond between the particular selected appliance and its intended tooth.

Abstract: An organic-inorganic hybrid composition comprising inorganic fine particles and a thermoplastic resin having a functional group capable of forming a chemical bond with the inorganic fine particles at a side chain thereof, the composition having a refractive index of 1.60 or more at a wavelength of 589 nm and a light transmittance of 70% or more at a wavelength of 589 nm in terms of the composition having a thickness of 1 mm. The composition has high refraction properties and excellent transparency.

Abstract: A phosphorus-containing polymer is provided comprising the reaction product of a chain-transfer agent having at least one pH bond with an unsaturated carboxylic, phosphonic or sulphonic acid. The invention also provides the aforementioned phosphorus-containing polymer further comprising phosphorus-containing end-caps. The polymers have a biodegradability of at least 20% per 28 days (as determined by OECD 306).

Abstract: The present application relates to a polymerizable dental adhesive system formulated for effective and durable bonding of zirconia based materials and restorations to dental resins and dental surfaces. According to one embodiment, a polymerizable dental adhesive system comprises a first acidic monomer comprising an ethylenically unsaturated polymerizable group or moiety of the general formula CH2?CX—C(O)— wherein X is hydrogen, methyl or a lower alkyl group, and the first polymerizable monomer further comprises a phosphoric or phosphonic acid group of general formula —OP(O)(OH)2, —OP(O)(OH), —C—P(O)(OH)2 and —C—P(O)(OH), and a second polymerizable acidic monomer comprises an ethylenically unsaturated polymerizable group or moiety of the general formula CH2?CX—C(O)— wherein X is hydrogen, methyl or a lower alkyl group, and wherein the second polymerizable acidic monomer further comprises a carboxylic acid group of the general formula —C(O)OH.

Abstract: Biocompatible copolymers are manufactured to include a zwitterionic monomer and an alkoxy acrylate monomer. The alkoxy acrylate monomer can be a 2-methoxyethyl methacrylate (MOEMA) or 2-ethoxyethyl methacrylate (EOEMA). Alternatively, the alkoxy acrylate can be 2-methoxyethyl acrylate (MOEA) or 2-ethoxyethyl acrylate (EOEA). The alkoxy acrylate monomers advantageously give the zwitterionic copolymers greater ductility, strength, and toughness while maintaining a desired amount of hydrophilicity. The improved toughness allows the zwitterionic copolymers to be processed without cross-linking, which improves the elongation properties of the zwitterionic copolymer, and reduces the risk of cracking during use.

Abstract: To provide an adhesive composition which shows high adhesion with a glass substrate and has excellent heat resistance, moisture resistance and moist heat resistance, an adhesive optical film comprising an adhesive layer made of the adhesive composition, which shows high adhesion between the adhesive layer and an optical film and effectively suppresses the occurrence of adhesive residue and lack of adhesive and also has excellent heat resistance, moisture resistance and moist heat resistance, and an image display device comprising the adhesive optical film, the adhesive optical film comprises an optical film 1, an adhesive layer 3 made of a water dispersible adhesive composition comprising, as raw monomers, an alkyl (meth)acrylate ester whose alkyl group has 4 to 18 carbon atoms, a carboxyl group-containing vinyl monomer, a phosphoric acid group-containing vinyl monomer, and a copolymerizable vinyl monomer which is optionally copolymerizable with the above monomers, wherein a carboxyl group concentration is fr

Abstract: Azidoaryl-substituted cyclooctene monomers and synthesized and used in the preparation of various copolymers. Among these copolymers are those prepared from ring-opening metathesis polymerization of cyclooctene, polyethylene glycol-substituted cyclooctene, and azidoaryl-substituted cyclooctene. These copolymers are useful in the formation of crosslinked films that reduce fouling of water purification membranes.

Abstract: Biocompatible terpolymers are manufactured to include a zwitterionic monomer, an alkoxy acrylate monomer, and a hydrophobic monomer.

Abstract: The present invention concerns a controlled structure copolymer comprising at least two different parts, a first part A, amphoteric or zwitterionic, including anionic or potentially anionic units, and cationic or potentially cationic units, or zwitterionic units, and another part B, non amphoteric or zwitterionic. Said copolymer further exhibits a high potential for adaptation, through variation in its composition, in order to improve or modify the properties of compositions in which it is introduced.

Abstract: The present invention relates to polymeric compositions useful in the manufacture of biocompatible medical devices. More particularly, the present invention relates to certain hydrophilic monomers capable of polymerization to form polymeric compositions having desirable physical characteristics useful in the manufacture of ophthalmic devices. The polymeric compositions comprise polymerizable hydrophilic siloxanyl monomers.

Abstract: The invention relates to anionically modified copolymers that can be produced by the polymerization of monomers (A), (B) and (C) to obtain non-ionic polymers with reactive terminal OH groups and by the subsequent reaction of the terminal OH groups to form anionic end groups. According to the invention, (A) is a monomer of formula (I), in which A represents C2-C4 alkene and B represents a C2-C4 alkene that is different from A, R represents hydrogen or methyl, m is a number between 1 and 500, n is a number between 1 and 500, (B) is an ethylenically unsaturated monomer containing an aromatic group and (C) is a ethylenically unsaturated monomer.

Abstract: The present invention provides a polymerizable composition that exhibits excellent adhesive properties to a tooth structure (particularly dentin) when applied as a dental material, and a polymerizable monomer that is used as a component of the polymerizable composition. The present invention is a polymerizable monomer (A) that is a compound having at least two polymerizable groups. The polymerizable monomer (A) has a retention time of 7 minutes to 30 minutes in a high-performance liquid chromatography (HPLC) measurement conducted under a condition in which a column with an inner diameter of 3.9 mm and a length of 300 mm, packed with a C18 packing material having been crushed to have an average particle size of 10 ?m and a pore size of 125 angstroms, is used, an eluent is a mixed solvent of methanol and water contained at a ratio of 3:7, a flow rate is 1.0 mL/minute, a measurement temperature is 50° C.

Abstract: The present invention is a phosphorylcholine-containing chemical compound represented by the following formula (1) or (2). (CH3)3N+CH2CH2PO4?CH2COOH??(1) (CH3)3N+CH2CH2PO4?CH2COONa??(2) The object of the present invention is to provide a new phosphorylcholine-containing compound that is useful as a surface treatment agent or a source material of a surface treatment agent. Another object is to provide a manufacturing method that has a high industrial utility value.